Science & Technology
Topic 447: Development and Testing of a Non-Invasive Cryo-Device to Prevent Chemotherapy-Induced Peripheral Neuropathy in Hands and Feet of Cancer Patients Receiving Taxol for Breast Cancer.
Department of Health and Human Services — National Institutes of Health
Opportunity #: 75N91023C00036
Award Ceiling
$400K
Award Floor
$400K
Close Date
N/A
Total Funding
$400K
Expected Awards
1
Cost Sharing Required
No
Grants.gov ID
sbir-75N91023C00036
Description
SBIR Phase Phase I award: "TOPIC 447: DEVELOPMENT AND TESTING OF A NON-INVASIVE CRYO-DEVICE TO PREVENT CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN HANDS AND FEET OF CANCER PATIENTS RECEIVING TAXOL FOR BREAST CANCER." awarded to EISANA CORP in THE WOODLANDS, Texas. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $399,824. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, Women-owned businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.